Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-24T13:40:40.311Z Has data issue: false hasContentIssue false

Risk factors associated with device embolisation or malposition during transcatheter closure of patent ductus arteriosus

Published online by Cambridge University Press:  14 December 2022

Zeeshan A. Mumtaz
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
Pramod Sagar
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
Kothandam Sivakumar*
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
Asish R. Mohakud
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
Monica Rajendran
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
Sreeja Pavithran
Affiliation:
Department of Pediatric Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, Chennai, India
*
Author for correspondence: Dr. K. Sivakumar MD DM, Head of Department of Pediatric Cardiology, Madras Medical Mission, 4A Dr JJ Nagar, Mogappair, Chennai 600089, India. Tel: +919444449966. E-mail drkumarsiva@hotmail.com

Abstract

Background:

Device embolisation is a serious adverse event during transcatheter duct closure. This study analyses risk factors for embolisation.

Methods:

Demographic parameters, echocardiographic anatomy, haemodynamics, and procedural characteristics of consecutive duct closures in a tertiary centre over 8 years were analysed. Procedures complicated by embolisation were compared to uncomplicated procedures.

Results:

Fifteen embolisations occurred during 376 procedures. All except one embolisation were in infants. The pulmonary artery: aortic pressure ratio was 0.78 ± 0.22. Embolisation was seen significantly more commonly in Type C tubular ducts. Vascular plugs were more significantly associated with embolisations. Logistic regression analysis showed device embolisation was significantly higher in age group of < 6 months compared to 6–12 months (p = 0.02), higher in those with tubular ducts versus conical ducts (p = 0.003), use of vascular plugs compared to conventional duct occluders (p = 0.05), and in duct closure with undersized devices (p = 0.001). There was no in-hospital mortality. Three patients needed surgical retrieval while others were successfully managed in catheterisation laboratory.

Conclusions:

Device embolisation complicates 4% of transcatheter duct closures, with need for surgery in one-fifth of them. Larger ducts with high pulmonary artery pressures in younger and smaller infants are more often associated with device embolisation. Tubular ducts are more prone for embolisation compared to usual conical ducts. Softer vascular plugs are often associated with embolisations. Intentional device undersizing to avoid vascular obstruction in small patients is a frequent risk factor for embolisation. Precise echocardiographic measurements, correct occluder choice, proper technique and additional care in patients with high pulmonary artery pressures are mandatory to minimise embolisations.

Type
Original Article
Copyright
© The Author(s), 2022. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Sathanandam, S, Balduf, K, Chilakala, S, et al. Role of transcatheter patent ductus arteriosus closure in extremely low birth weight infants. Catheter Cardiovasc Interv 2019; 93: 8996.10.1002/ccd.27808CrossRefGoogle ScholarPubMed
Sathanandam, S, Agrawal, H, Chilakala, S, et al. Can transcatheter PDA closure be performed in neonates ≤1000 grams? The Memphis experience congenit heart dis 2019, 14:7984.10.1111/chd.12700CrossRefGoogle Scholar
Sen, S, Jain, S, Dalvi, B. Embolisation of ceramic-coated PDA devices into the descending thoracic aorta: probable mechanisms and retrieval strategies. Cardiol Young 2019; 29: 842844.10.1017/S104795111900091XCrossRefGoogle ScholarPubMed
Sathanandam, S, Gutfinger, D, Morray, B, et al. Consensus guidelines for the prevention and management of periprocedural complications of transcatheter patent ductus arteriosus closure with the amplatzer piccolo occluder in extremely low birth weight infants. Pediatr Cardiol 2021; 42: 12581274.10.1007/s00246-021-02665-3CrossRefGoogle ScholarPubMed
Benson, LN, Burrows, P, Ml, CAF, McLaughlin, P, Freedom, RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and lmplications for percutaneous catheter occlusion. Am J Cardiol 1989; 63: 877880.Google Scholar
Anil, SR, Sivakumar, K, Kumar, RK. Coil occlusion of the small patent arterial duct without arterial access. Cardiol Young 2002; 12: 5156.10.1017/S1047951102000094CrossRefGoogle ScholarPubMed
Kang, S-L, Jivanji, S, Mehta, C, et al. Outcome after transcatheter occlusion of patent ductus arteriosus in infants less than 6 kg: a national study from United Kingdom and ireland. Catheter Cardiovasc Interv 2017; 90: 11351144.10.1002/ccd.27212CrossRefGoogle ScholarPubMed
Backes, CH, Rivera, BK, Bridge, JA, et al. Percutaneous patent ductus arteriosus closure during infancy: a meta-analysis. Pediatrics 2017; 139: e20162927.10.1542/peds.2016-2927CrossRefGoogle ScholarPubMed
Tan, CA, Levi, DS, Moore, JW. Embolization and transcatheter retrieval of coils and devices. Pediatr Cardiol 2005; 26: 267274.10.1007/s00246-005-1009-1CrossRefGoogle ScholarPubMed
El-said, HG, Bratincsak, A, Foerster, SR, et al. Safety of percutaneous patent ductus arteriosus closure: an unselected multicentre population experience J am heart assoc 2013;, 2:e000424.10.1161/JAHA.113.000424CrossRefGoogle Scholar
Sivakumar, K, Francis, E, Krishnan, P. Safety and feasibility of transcatheter closure of large patent ductus arteriosus measuring >4mm in patients weighing <6kg. J Interven Cardiol 2008; 21: 196203.10.1111/j.1540-8183.2008.00348.xCrossRefGoogle Scholar
Faella, HJ, Hijazi, ZM. Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 2000; 51: 5054.10.1002/1522-726X(200009)51:1<50::AID-CCD11>3.0.CO;2-63.0.CO;2-6>CrossRefGoogle ScholarPubMed
Jang, GY, Son, CS, Lee, JW, Lee, JY, Kim, SJ. Complications after transcatheter closure of patent ductus arteriosus. J Korean Med Sci 2007; 22: 484.10.3346/jkms.2007.22.3.484CrossRefGoogle ScholarPubMed
Tomasulo, CE, Gillespie, MJ, Munson, D, et al. Incidence and fate of device-related left pulmonary artery stenosis and aortic coarctation in small infants undergoing transcatheter patent ductus arteriosus closure. Catheter Cardiovasc Interv 2020; 96: 889897.10.1002/ccd.28942CrossRefGoogle ScholarPubMed
Kharouf, R, Heitschmidt, M, Hijazi, ZM. Pulmonary perfusion scans following transcatheter patent ductus arteriosus closure using the amplatzer devices. Catheter Cardiovasc Interv 2011; 77: 664670.10.1002/ccd.22917CrossRefGoogle ScholarPubMed
Supplementary material: File

Mumtaz et al. supplementary material

Table S2

Download Mumtaz et al. supplementary material(File)
File 26.5 KB
Supplementary material: File

Mumtaz et al. supplementary material

Table 1

Download Mumtaz et al. supplementary material(File)
File 16.2 KB